Skip to content

Author

Andrea Sorrentino

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

CO078 | METABOLOMIC AND LIPOPROTEOMIC MODULATION FOLLOWING INCLISIRAN TREATMENT IN DYSLIPIDEMIC PATIENTS

Background and Aims. Inclisiran is a subcutaneously administrated synthetic small interfering RNA directed against proprotein convertase subtilisin–kexin type 9, leading to sustained low-density lipoprotein cholesterol (LDL-C) reduction with a twice-yearly dosing regimen. While its lipid-lowering efficacy is well estab...

Andrea Sorrentino · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.